No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate-to-severe plaque psoriasis

被引：180
|
作者：
Strober, B. E. [1 ,2 ]
Langley, R. G. B. [3 ]
Menter, A. [4 ]
Magid, M. [5 ]
Porter, B. [6 ]
Fox, T. [7 ]
Safi, J., Jr. [6 ]
Papavassilis, C. [7 ]
机构：
[1] Univ Connecticut, Ctr Hlth, Dept Dermatol, Farmington, CT 06030 USA
[2] Prob Med Res, Waterloo, ON, Canada
[3] Dalhousie Univ, Div Clin Dermatol & Cutaneous Sci, Halifax, NS, Canada
[4] Baylor Univ, Med Ctr, Div Dermatol, Dallas, TX USA
[5] UT Austin, Seton Family Hosp, Dept Psychiat, Austin, TX USA
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] Novartis Pharma AG, Basel, Switzerland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2018年 / 178卷 / 02期
关键词：
POPULATION-BASED-COHORT;
D O I：
10.1111/bjd.16051
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E105 / E107
页数：3
相关论文
共 50 条
  • [1] Evaluation of Infections With Secukinumab in a Pooled Analysis of 10 Clinical Studies of Moderate-to-Severe Plaque Psoriasis
    Tsai, T.
    Blauvelt, A.
    Karpov, A.
    Huang, J.
    Cooper, S.
    Fox, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S33 - S33
  • [2] Evaluation of Malignancy Risk With Secukinumab Treatment in a Pooled Analysis of 10 Clinical Studies of Moderate-to-Severe Plaque Psoriasis up to 52 Weeks
    van de Kerkhof, P.
    Strober, B.
    Karpov, A.
    Huang, J.
    Cooper, S.
    Fox, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S33 - S33
  • [3] Secukinumab safety in subjects with moderate to severe plaque psoriasis: A pooled analysis of neutropenia from 10 clinical studies
    Griffiths, Cristopher
    Guettner, Achim
    Prinz, Jorg
    Cooper, Simon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB188 - AB188
  • [4] Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis
    Wong, Ian T. Y.
    Shojania, Kam
    Dutz, Jan
    Tsao, Nicole W.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) : 153 - 166
  • [5] Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
    Alan Menter
    Jennifer C. Cather
    Michael Jarratt
    Xiangyi Meng
    Adriana Guana
    Judit Nyirady
    Dermatology and Therapy, 2016, 6 : 639 - 647
  • [6] Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
    Menter, Alan
    Cather, Jennifer C.
    Jarratt, Michael
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    DERMATOLOGY AND THERAPY, 2016, 6 (04) : 639 - 647
  • [7] Secukinumab improves anxiety and depression in patients with moderate-to-severe psoriasis: results from the SUPREME study
    Talamonti, M.
    Malara, G.
    Natalini, Y.
    Bardazzi, F.
    Conti, A.
    Chiricozzi, A.
    Mugheddu, C.
    Gisondi, P.
    Piaserico, S.
    Pagnanelli, G.
    Amerio, P.
    Potenza, C.
    Cantoresi, F.
    Fargnoli, M. C.
    Balato, A.
    Loconsole, F.
    Offidani, A. M.
    Bonifati, C.
    Prignano, F.
    Bartezaghi, M.
    Aloisi, E.
    Orsenigo, R.
    Costanzo, Antonio
    Bian, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 27 - 28
  • [8] Pooled safety analysis from two phase III studies of secukinumab in paediatric patients with moderate-to-severe plaque psoriasis up to week 52
    Sticherling, M.
    Nikkels, A. F.
    Hamza, A. M.
    Kwong, P.
    Ortmann, C. -E.
    Papanastasiou, P.
    Forrer, P.
    Keefe, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E39 - E40
  • [9] Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
    Griffiths, Christopher
    Reich, Kristian
    Leonard, Craig
    Blauvelt, Andrew
    Mehta, Nehal
    Tsai, Tsen-Fang
    Gong, Yankun
    Huang, Jiaqing
    Fox, Todd
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S14 - S14
  • [10] Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
    Foley, P.
    Griffiths, C.
    Reich, K.
    Leonardi, C. L.
    Blauvelt, A.
    Mehta, N. N.
    Tsai, T. F.
    Gong, Y.
    Papavassilis, C.
    Huang, J.
    Fox, T.
    van de Kerkhof, P.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 50 - 50
12345